Given the importance of IRF5 as a potential biomarker for autoimmune disease and cancer, we evaluated the ability of antibodies to detect IRF5 by immunohistochemical (IHC) and immunofluorescence (IF) microscopy in human splenic tissue. Here, IRF5 is linked to cancer.